The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria

Yuki Tamura, Siro Simizu, Hiroyuki Osada

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2ΔTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2ΔTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2ΔTM. These observations suggest that Bcl-2ΔTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiological regulators of Bcl-2 phosphorylation, and these enzymes exert an influence on the anti-apoptotic function of Bcl-2.

Original languageEnglish
Pages (from-to)249-255
Number of pages7
JournalFEBS Letters
Volume569
Issue number1-3
DOIs
Publication statusPublished - 2004 Jul 2
Externally publishedYes

Fingerprint

Protein Phosphatase 2
Phosphorylation
Mitochondria
Extracellular Signal-Regulated MAP Kinases
Phosphotransferases
Tumor Cell Line
Tumors
Cells
Mitogen-Activated Protein Kinase Kinases
Proteins
Apoptosis
Enzymes

Keywords

  • Apoptosis
  • Bcl-2
  • CPT, camptothecin
  • ERK, extracellular-signal-regulated kinase 1 and 2
  • Extracellular-signal-regulated kinase
  • JNK, c-Jun N-terminal kinase 1 and 2
  • MAPK, mitogen-activated protein kinase
  • Phosphorylation
  • Protein phosphatase 2A

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. / Tamura, Yuki; Simizu, Siro; Osada, Hiroyuki.

In: FEBS Letters, Vol. 569, No. 1-3, 02.07.2004, p. 249-255.

Research output: Contribution to journalArticle

@article{8b72cc411ef943cdbe77614e6d88ad17,
title = "The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria",
abstract = "Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2ΔTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2ΔTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2ΔTM. These observations suggest that Bcl-2ΔTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiological regulators of Bcl-2 phosphorylation, and these enzymes exert an influence on the anti-apoptotic function of Bcl-2.",
keywords = "Apoptosis, Bcl-2, CPT, camptothecin, ERK, extracellular-signal-regulated kinase 1 and 2, Extracellular-signal-regulated kinase, JNK, c-Jun N-terminal kinase 1 and 2, MAPK, mitogen-activated protein kinase, Phosphorylation, Protein phosphatase 2A",
author = "Yuki Tamura and Siro Simizu and Hiroyuki Osada",
year = "2004",
month = "7",
day = "2",
doi = "10.1016/j.febslet.2004.06.003",
language = "English",
volume = "569",
pages = "249--255",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria

AU - Tamura, Yuki

AU - Simizu, Siro

AU - Osada, Hiroyuki

PY - 2004/7/2

Y1 - 2004/7/2

N2 - Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2ΔTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2ΔTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2ΔTM. These observations suggest that Bcl-2ΔTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiological regulators of Bcl-2 phosphorylation, and these enzymes exert an influence on the anti-apoptotic function of Bcl-2.

AB - Bcl-2 protein play important roles in the regulation of apoptosis. We previously reported that the phosphorylation of Bcl-2 was augmented by treatment with protein phosphatase 2A (PP2A) inhibitor; however, the kinase responsible for Bcl-2 phosphorylation had not yet been identified. In this study, we identified extracellular-signal-regulated kinase (ERK) as the responsible kinase for the phosphorylation of Bcl-2. We also found that the transmembrane region (TM) deleted form of Bcl-2 (Bcl-2ΔTM), which was unable to localize on the mitochondria was constitutively phosphorylated, whereas wild-type Bcl-2 that localized on the mitochondria, was present in its hypophosphorylated form. The phosphorylation of Bcl-2ΔTM was retarded by treatment with MAP kinase ERK kinase (MEK) inhibitor and PP2A did not bind to Bcl-2ΔTM. These observations suggest that Bcl-2ΔTM is constitutively phosphorylated by ERK, but is not dephosphorylated by PP2A in human tumor cell lines. The phosphorylation of Bcl-2 resulted in a reduction in anti-apoptotic function, implying that dephosphorylation promoted the anti-apoptotic activity of Bcl-2 protein in human tumor cell lines. Thus, the present findings suggest that ERK and PP2A are physiological regulators of Bcl-2 phosphorylation, and these enzymes exert an influence on the anti-apoptotic function of Bcl-2.

KW - Apoptosis

KW - Bcl-2

KW - CPT, camptothecin

KW - ERK, extracellular-signal-regulated kinase 1 and 2

KW - Extracellular-signal-regulated kinase

KW - JNK, c-Jun N-terminal kinase 1 and 2

KW - MAPK, mitogen-activated protein kinase

KW - Phosphorylation

KW - Protein phosphatase 2A

UR - http://www.scopus.com/inward/record.url?scp=3042549655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042549655&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2004.06.003

DO - 10.1016/j.febslet.2004.06.003

M3 - Article

C2 - 15225643

AN - SCOPUS:3042549655

VL - 569

SP - 249

EP - 255

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 1-3

ER -